Telbivudine - Investigational Drug for Chronic Hepatitis B Infection

 

Key Data:

Drug (Brand / Generic)
Telbivudine / Tyzeka / Sebivo
Company / Licensee
Idenix Pharmaceuticals / Novartis Pharma
Therapy Class
Nucleotide analogue
Product Description
Oral L-deoxythymidine
Current Indication
Chronic HBV infection
Market Sector
Antiinfectives
Development Status
Approved in the US, EU and several Asian countries



Home
New On This Site
Products & Services
Company A-Z
Industry Projects
Features
White Papers
Jobs & Careers
Industry News
Gallery
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area


RSS What is RSS
For every phase of your drug development